Dr. Carolyne Elbaz is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at Centre hospitalier de St-Mary, Hematologie in Montréal, QC, she is part of a dedicated healthcare team committed to providing comprehensive blood disorder care. Her practice adheres to the high standards set by the Collège des médecins du Québec (CMQ), ensuring quality and safety in all aspects of patient care. She addresses a wide array of benign and malignant hematologic disorders, offering both diagnostic expertise and therapeutic interventions. Her approach emphasizes personalized treatment plans tailored to each patient's unique condition and needs, with access to advanced diagnostic and treatment facilities that support optimal outcomes for adults with suspected or diagnosed blood disorders or cancers.
Dr. Elbaz graduated with a Medical Degree in 2020 and has been practicing as a Hematologist for over 4 years, since 2020. She completed extensive post-graduate medical training and certification in Hematology (Blood Disorders), ensuring her expertise aligns with the latest clinical guidelines and research developments. Her training includes specialized diagnostics, therapeutic procedures, and multidisciplinary collaboration to deliver comprehensive blood disorder management.
Her clinical philosophy centers on multidisciplinary care, evidence-based treatment, and patient and family support. Dr. Elbaz is dedicated to advancing research in hematology and providing compassionate, patient-centered care within Montréal. She speaks French fluently, facilitating clear communication and understanding with her diverse patient community. Her commitment is to improve quality of life through innovative, individualized treatment strategies and ongoing patient education.
Dr. Carolyne Elbaz has expertise in managing a wide range of conditions, including:
Hematologic Malignancies (Blood Cancers) Treated
- Multiple Myeloma: A cancer of plasma cells, a type of white blood cell in the bone marrow that produces antibodies, leading to bone damage and other complications.
- Myelodysplastic Syndromes (MDS): A group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy, mature blood cells.
- Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
- Vitamin B12 & Folate Deficiency Anemias: Anemias resulting from a lack of vitamin B12 or folate, essential for red blood cell formation.
- Sickle Cell Disease & Thalassemia Syndromes: Inherited disorders affecting the structure or production of hemoglobin, leading to various complications.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Carolyne Elbaz or your referring physician.
- Second Opinion Consultations for Cancer & Blood Disorders: Providing expert second opinions on complex diagnoses and proposed treatment plans to ensure informed decision-making.
- Bone Marrow Aspiration & Biopsy (Performance or Interpretation): Performing or interpreting samples from bone marrow aspirations and biopsies to diagnose blood disorders and cancers.
- Comprehensive Oncologic & Hematologic Consultation: In-depth evaluation of medical history, review of diagnostic imaging and pathology, cancer staging (if applicable), and development of personalized treatment plans for various cancers and blood disorders.
- Autologous & Allogeneic Stem Cell Transplant Consultation, Coordination & Post-Transplant Care (as part of a transplant team or referral network): Evaluating eligibility for, coordinating referrals to, and providing follow-up care for patients undergoing stem cell transplantation for hematologic malignancies.
- Interpretation of Special Hematologic Tests (e.g., Flow Cytometry, Cytogenetics, Molecular Studies): Analyzing results from advanced laboratory tests crucial for diagnosing and classifying hematologic conditions.
- Diagnosis & Management of Multiple Myeloma, Waldenström's Macroglobulinemia & Other Plasma Cell Dyscrasias: Specialized care for cancers arising from plasma cells, utilizing novel agents, chemotherapy, and supportive care, including stem cell transplant coordination.
- Neutropenia & Other White Blood Cell Disorders Evaluation: Investigating and managing low or abnormal white blood cell counts, increasing susceptibility to infections.
Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Elbaz provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Elbaz or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Centre hospitalier de St-Mary, Hematologie is situated in the vibrant Côte-des-Neiges Central (UdeM area) neighborhood of Montréal. The clinic is conveniently located near Parc Lafontaine Access, making it accessible for patients from various parts of the city. Public transit options are plentiful, with close proximity to Société de transport de Montréal (STM) services, including Métro and Bus routes. The facility is wheelchair accessible, ensuring ease of access for all patients. Parking is available at the facility for those who prefer to drive, providing a seamless experience for visitors seeking expert blood disorder care from Dr. Elbaz.
- Are consultations and treatments with Dr. Elbaz, an Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Elbaz are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Elbaz's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Elbaz, an Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Elbaz for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What is palliative care, and when might Dr. Elbaz discuss it?
- Palliative care is specialized medical care focused on providing relief from the symptoms and stress of a serious illness, like cancer or advanced blood disorders. The goal is to improve quality of life for both the patient and the family. It can be provided at any stage of illness, alongside curative treatments, not just at the end of life. Dr. Elbaz may discuss palliative care if you are experiencing significant symptoms, to help manage pain, fatigue, nausea, anxiety, or other issues, and to provide an extra layer of support.
- How will treatment decisions be made for my condition by Dr. Elbaz?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Elbaz will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
- What kind of supportive care is available during cancer or hematology treatment with Dr. Elbaz?
- Supportive care is a crucial part of treatment, aiming to manage symptoms, reduce side effects, improve quality of life, and address emotional and practical needs. This can include effective pain and symptom management, nutritional support and counseling, psychological support (counseling, therapy), social work services for practical and emotional support, physiotherapy or occupational therapy, access to patient support groups, and spiritual care. Dr. Elbaz and the healthcare team at affiliated hospitals or cancer centres can connect you with these valuable resources.
- What are common side effects of chemotherapy, and how does Dr. Elbaz help manage them?
- Chemotherapy can cause various side effects, which differ depending on the specific drugs used, the dose, and individual patient factors. Common ones include fatigue, nausea, vomiting, hair loss, mouth sores, changes in appetite, diarrhea or constipation, and increased risk of infection due to low blood counts. Dr. Elbaz and the oncology nursing team will discuss potential side effects of your specific treatment plan in detail and will actively work to prevent and manage them with medications (e.g., anti-nausea drugs, growth factors to boost blood counts), supportive care advice (nutrition, hydration, rest), and regular monitoring. Open communication about any side effects you experience is very important for effective management.
Centre hospitalier de St-Mary, Hematologie
B-242-3830 av Lacombe
Montréal, QC H3T 1M5
Phone: (514) 345-3511 | Fax: (514) 734-2755
The facility is wheelchair accessible.
Dr. Elbaz is a licensed Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=20827